{"id":"placebo-vaginal-lubricant","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL2107924","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo vaginal lubricants are inert formulations used in phase 3 trials to establish efficacy of active vaginal lubricant candidates through comparison against a non-therapeutic control. They mimic the physical properties and administration route of active treatments but contain no bioactive ingredients, allowing researchers to isolate the true therapeutic benefit of investigational agents.","oneSentence":"A placebo vaginal lubricant provides no active pharmacological effect and serves as a control comparator in clinical trials.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:28:59.760Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control arm in clinical trials for vaginal dryness or related conditions"}]},"trialDetails":[{"nctId":"NCT06828640","phase":"NA","title":"Treatment of Vulvo-vaginal Atrophy (VVA) Using Vaginal Dilator in Addition to Usual Treatment","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire Saint Pierre","startDate":"2024-10-16","conditions":"Vulvo Vaginal Atrophy, Genitourinary Syndrome of Menopause (GSM), Vaginal Atrophy in Breast Cancer Patients","enrollment":160},{"nctId":"NCT05493735","phase":"PHASE3","title":"Lidocaine for Pessary Check Pain Reduction","status":"COMPLETED","sponsor":"University of South Florida","startDate":"2022-09-08","conditions":"Pelvic Organ Prolapse, Stress Urinary Incontinence","enrollment":66},{"nctId":"NCT05702567","phase":"NA","title":"The Effectiveness of Transvaginal Radiofrequency in Women With Stress Urinary Incontinence","status":"COMPLETED","sponsor":"José Casaña Granell","startDate":"2023-01-09","conditions":"Urinary Incontinence,Stress, Pelvic Floor Disorders, Urinary Incontinence","enrollment":42},{"nctId":"NCT03769688","phase":"PHASE1","title":"Safety and Efficacy of Vaginal Microbiota Transplant (VMT) in Women With Bacterial Vaginosis (BV)","status":"WITHDRAWN","sponsor":"Johns Hopkins University","startDate":"2022-03","conditions":"Bacterial Vaginosis","enrollment":""},{"nctId":"NCT02738203","phase":"PHASE3","title":"Self-Administered Lidocaine Gel for Pain Management With IUD Insertion","status":"COMPLETED","sponsor":"Stanford University","startDate":"2016-06-01","conditions":"IUD Insertion","enrollment":220},{"nctId":"NCT00729469","phase":"PHASE3","title":"Efficacy and Safety of Ospemifene in the Treatment of Moderate to Severe Vaginal Dryness and Vaginal Pain Associated With Sexual Activity","status":"COMPLETED","sponsor":"Shionogi","startDate":"2008-07","conditions":"Atrophy, Vaginal Diseases","enrollment":919},{"nctId":"NCT01755741","phase":"PHASE1","title":"Functionality of Male Condoms With a Silicone Elastomer Vaginal RIng","status":"COMPLETED","sponsor":"International Partnership for Microbicides, Inc.","startDate":"2013-02","conditions":"Human Immunodeficiency Virus","enrollment":70},{"nctId":"NCT00981305","phase":"PHASE3","title":"Impact of Lactate-Containing Vaginal Lubricant on Sexual Dysfunction in Young Breast Cancer Survivors","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2009-09","conditions":"Sexual Dysfunction, Breast Cancer Survivors","enrollment":136},{"nctId":"NCT02462954","phase":"PHASE1","title":"A Safety Study Of The Caya® Diaphragm Used With ContraGel®","status":"COMPLETED","sponsor":"CONRAD","startDate":"2015-07","conditions":"Contraception","enrollment":23},{"nctId":"NCT00276094","phase":"PHASE3","title":"A Clinical Study to Evaluate Ospemifene in the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women","status":"COMPLETED","sponsor":"Shionogi","startDate":"2006-01","conditions":"Atrophy, Vaginal Diseases","enrollment":826},{"nctId":"NCT00607295","phase":"PHASE3","title":"Efficacy and Safety of Clino-san on Vaginal Dryness of Breast Cancer Patients","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2007-12","conditions":"Breast Cancer, Vaginal Atrophy","enrollment":98}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["placebo","Replens"],"phase":"phase_3","status":"active","brandName":"Placebo vaginal lubricant","genericName":"Placebo vaginal lubricant","companyName":"Seoul National University Hospital","companyId":"seoul-national-university-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A placebo vaginal lubricant provides no active pharmacological effect and serves as a control comparator in clinical trials. Used for Control arm in clinical trials for vaginal dryness or related conditions.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}